-
On December 11, 2021, CH Biomedical officially launched its CH-VAD®, the implantable ventricular assist system (VAS) during the Critical Heart Disease Conference (CHDC). This milestone marks the beginning of commercialization for China’s first fully magnetically levitated VAD with complete independent intellectual property rights.
-
On November 24th 2021, the implantable CH-VAD® left ventricular assist system (CH-VAD® LVAS) of CH Biomedical was approved by the National Medical Products Administration (NMPA) for marketing (Registration No.: GXZZ 20213120987). CH-VAD LVAS was developed independently by CH Biomedical, it is the first Left Ventricular Assist Device (LVAD) with complete independent intellectual property rights approved by NMPA in China, and the first full magnetic levitation LVAD approved by NMPA.
-
From October 21 to 27, the “13th Five-Year Plan” Scientific and Technological Innovation Achievement Exhibition was held at the Beijing Exhibition Center. CH Biomedical’s CH-VAD, was showcased in the Social Development Section as a representative of China’s high-end medical devices.
-
In March 2021, the National Medical Products Administration (NMPA) appointed Jiangsu Medical Products Administration to carry out on-site inspection of Good Manufacturing Practice (GMP) quality management system of CH Biomedical. Inspection results showed that CH Biomedical is in compliance with GMP regulations without key nonconformities.
-
On January 5, 2020, "China’s First Mechanical Circulatory Support Conference" and "The First Preparatory Meeting of Mechanical Circulatory Support (MCS) Branch of Chinese Society of Biomedical Engineering (CSBE) " sponsored by National Center for Cardiovascular Diseases (NCCD) and Fuwai Hospital were held in Beijing.
-
In September 2019, the 26th Annual Meeting of the International Society Mechanical Circulatory Support (ISMCS) was held in Japan. CH Biomedical was invited to participate in this conference for the first time, indicating that the company has become one of the most recognized VAD enterprises today.
